The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

European shares set for positive start

Thu, 09th Feb 2023 07:44

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at

EUROPEAN SHARES SET FOR POSITIVE START (0737 GMT)

Shares in Europe are expected to rise this morning, tracking a bounce in U.S. futures and following data showing German inflation rose by a less than anticipated 9.2% in January, which could ease pressure on the ECB to keep raising rates.

EuroSTOXX 50 and FTSE futures are up 0.6% and 0.3%, respectively, and S&P 500 contracts added 0.4%.

On another heavy day in Europe's earnings season, eyes are on Credit Suisse. The Swiss bank posted its worst annual loss since 2008 and warned that a further "substantial" loss would come this year. Its shares were down 4.7% in the premarket.

On a more upbeat note, Credit Agricole posted a higher-than-expected profit, driven by lower loan provisions and a strong performance at its investment banking division.

In the UK, Unilever reported quarterly underlying sales growth above expectations and AstraZeneca posted fourth-quarter revenue just shy of analyst estimates.

BAR-DUH (0656 GMT)

Surely the most fun story today, unless you are an Alphabet shareholder, is Google's new Bard AI flunking a question on the James Webb telescope. And it was an own goal given the error was in a Twitter video put out by Google itself, ouch.

Alphabet's shares sank almost 8%, wiping a cool $100 billion off its market cap, and dragging all of Wall Street down. But it did produce one of our best headlines of the session: "Alphabet's Bard apparently no Shakespeare." Eat your heart out AI.

There's been scant fun in Asian markets with everyone already stressing about next week's U.S. CPI report and what that will mean for the likely peak of Fed rates.

In Europe, the Riksbank meeting will be interesting if only because both the governor and deputy are new to the roles, so there's no knowing if the central bank's reaction function has changed.

Markets are priced for a half-point hike to 3.0%, in part to match the ECB and stop the SEK from weakening yet further. It's been falling steadily on the euro since late 2021, making it all the harder to fight inflation.

Assuming it goes 50 bps, and not 75 bps, the focus will be on the outlook for further tightening. Markets are fully priced for a move to 3.25%, with 3.5% an even bet.

If this week's hikes by central banks in India and Australia are anything to go by, the risk is for a hawkish outcome in Sweden.

Further out, JPMorgan analysts note household debt in Sweden is twice the EU average making it tough for the Riksbank to keep a half-point spread over ECB rates.

"Monetary policy in Sweden is clearly more restrictive than in the Euro-area," they say. "If the ECB therefore ends up with a 3.25% terminal rate (our forecast), we think the Riksbank will not be able to follow suit and take the policy rate to 3.75%."

There are blessedly no Fed speakers today, but Bank of England Governor Andrew Bailey will be grilled by lawmakers - among the few people in the country not on strike - about its recent rate rise and the ever-growing risk of recession.

The BoE line has been they may have done enough, but are not sure and are ready to do more if needed.

Key developments that could influence markets on Thursday:

- Riksbank rate decision and Feb monetary policy report due at 0830 GMT. Governor Erik Thedéen and Jesper Hansson, head of the Monetary Policy Department hold presser at 1000 GMT

- BoE Governor Bailey speaks to lawmakers at 0945 GMT

- The delayed German Jan CPI is due at 0700 GMT and could cause fireworks if stronger than the forecast 8.9% y/y

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.